![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.indianpharmapost.com/news/jubilant-pharmova-to-close-manufacturing-operations-of-solid-dosage-formulation-facility-of-jubilant-cadista-usa-15540
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/jubilant-gets-vai-classification-from-usfda-for-roorkee-unit/articleshow/109374782.cms
https://www.fiercepharma.com/manufacturing/fda-slams-jubilant-generics-canadas-contract-pharmaceuticals-form-483s
https://www.pharmacompass.com/pdf/news/fda-issues-form-483-to-jubilant-generics-83160.pdf
https://www.business-standard.com/markets/capital-market-news/jubilant-generics-roorkee-site-completes-usfda-audit-124020300319_1.html
https://www.indianpharmapost.com/news/usfda-determines-inspection-classification-of-jubilant-pharmovas-roorkee-facility-13237
https://www.pharmacompass.com/pdf/news/fda-issues-form-483-to-jubilant-generics-ltd-43625.pdf
https://endpts.com/indian-site-for-jubilant-generics-lands-form-483-for-qc-issues/
https://www.pharmacompass.com/pdf/news/jubilant-generics-roorkee-is-on-health-canada-inspection-list-1634649050.pdf
https://www.pharmacompass.com/pdf/news/fda-issues-form-483-to-jubilant-generics-1629441390.pdf